首页 > 最新文献

JMIR Cardio最新文献

英文 中文
Evaluation of the Effectiveness of Advanced Technology Clinical Simulation Manikins in Improving the Capability of Australian Paramedics to Deliver High-Quality Cardiopulmonary Resuscitation: Pre- and Postintervention Study. 先进技术临床模拟人体模型在提高澳大利亚护理人员提供高质量心肺复苏能力方面的有效性评估:干预前和干预后研究。
Q2 Medicine Pub Date : 2024-12-24 DOI: 10.2196/49895
Alison Zucca, Jamie Bryant, Jeffrey Purse, Stuart Szwec, Robert Sanson-Fisher, Lucy Leigh, Mike Richer, Alan Morrison
<p><strong>Background: </strong>Emergency medical services attend out-of-hospital cardiac arrests all across Australia. Resuscitation by emergency medical services is attempted in nearly half of all cases. However, resuscitation skills can degrade over time without adequate exposure, which negatively impacts patient survival. Consequently, for paramedics working in areas with low out-of-hospital cardiac arrest case volumes, ambulance services and professional bodies recognize the importance of alternative ways to maintain resuscitation skills. Simulation-based training via resuscitation manikins offers a potential solution for maintaining paramedic clinical practice skills.</p><p><strong>Objective: </strong>The aim of the study is to examine the effectiveness of advanced technology clinical simulation manikins and accompanying simulation resources (targeted clinical scenarios and debriefing tools) in improving the demonstrable capability of paramedics to deliver high-quality patient care, as measured by external cardiac compression (ECC) performance.</p><p><strong>Methods: </strong>A pre- and postintervention study design without a control group was used. Data were collected at the start of the manikin training forum (baseline), immediately following the training forum (time 2), and 6 to 11 months after the training forum (time 3). The study was conducted with paramedics from 95 NSW Ambulance locations (75 regional locations and 20 metropolitan locations). Eligible participants were paramedics who were employed by NSW Ambulance (N=106; 100% consent rate). As part of the intervention, paramedics attended a training session on the use of advanced technology simulation manikins. Manikins were then deployed to locations for further use. The main outcome measure was an overall compression score that was automatically recorded and calculated by the simulator manikin in 2-minute cycles. This score was derived from compressions that were fully released and with the correct hand position, adequate depth, and adequate rate.</p><p><strong>Results: </strong>A total of 106 (100% consent rate) paramedics participated, primarily representing regional ambulance locations (n= 75, 78.9%). ECC compression scores were on average 95% or above at all time points, suggesting high performance. No significant differences over time (P>.05) were identified for the overall ECC performance score, compressions fully released, compressions with adequate depth, or compressions with the correct hand position. However, paramedics had significantly lower odds (odds ratio 0.30, 95% CI 0.12-0.78) of achieving compressions with adequate rate at time 3 compared to time 2 (P=.01). Compressions were of a slower rate, with an average difference of 2.1 fewer compressions every minute.</p><p><strong>Conclusions: </strong>Despite this difference in compression rate over time, this did not cause significant detriment to overall ECC performance. Training and deployment of simulator manikins d
背景:紧急医疗服务参加院外心脏骤停全澳大利亚。在所有病例中,近一半的人试图通过紧急医疗服务进行复苏。然而,如果没有足够的暴露,复苏技能会随着时间的推移而退化,这对患者的生存产生负面影响。因此,对于在院外心脏骤停病例量低的地区工作的护理人员,救护车服务和专业机构认识到维持复苏技能的替代方法的重要性。通过复苏人体模型进行的基于模拟的培训为维持护理人员的临床实践技能提供了一个潜在的解决方案。目的:该研究的目的是检验先进技术临床模拟人体模型和伴随的模拟资源(有针对性的临床场景和汇报工具)在提高护理人员提供高质量患者护理的可论证能力方面的有效性,这是通过心外按压(ECC)性能来衡量的。方法:采用不设对照组的干预前后研究设计。数据在人体模型培训论坛开始时(基线)、培训论坛结束后(时间2)和培训论坛结束后6至11个月(时间3)收集。该研究由来自95个新南威尔士州救护车地点(75个地区地点和20个大都市地点)的护理人员进行。符合条件的参与者是受雇于NSW救护车的护理人员(N=106;100%同意率)。作为干预措施的一部分,护理人员参加了一个关于使用先进技术模拟人体模型的培训课程。人体模型随后被部署到其他地点以供进一步使用。主要结果测量是总压缩评分,由模拟人体在2分钟周期内自动记录和计算。该评分来源于完全释放的压迫,以及正确的手位、适当的深度和适当的速率。结果:共有106名(100%同意率)护理人员参与,主要代表区域救护车点(n= 75, 78.9%)。在所有时间点,ECC压缩分数平均为95%或更高,表明性能很高。随着时间的推移,在整体ECC性能评分、完全释放的压迫、足够深度的压迫或正确手位的压迫方面,没有发现显著差异(P>.05)。然而,与时间2相比,护理人员在时间3获得适当按压率的几率明显较低(比值比0.30,95% CI 0.12-0.78) (P= 0.01)。压缩速率较慢,平均每分钟减少2.1次压缩。结论:尽管随着时间的推移压缩率存在差异,但这并不会对整体ECC性能造成显著损害。训练和部署模拟人体模型并没有显著改变护理人员的整体ECC性能。本样本中护理人员的高基线表现(天花板效应)可能阻碍了技能和表现的潜在增长。
{"title":"Evaluation of the Effectiveness of Advanced Technology Clinical Simulation Manikins in Improving the Capability of Australian Paramedics to Deliver High-Quality Cardiopulmonary Resuscitation: Pre- and Postintervention Study.","authors":"Alison Zucca, Jamie Bryant, Jeffrey Purse, Stuart Szwec, Robert Sanson-Fisher, Lucy Leigh, Mike Richer, Alan Morrison","doi":"10.2196/49895","DOIUrl":"10.2196/49895","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Emergency medical services attend out-of-hospital cardiac arrests all across Australia. Resuscitation by emergency medical services is attempted in nearly half of all cases. However, resuscitation skills can degrade over time without adequate exposure, which negatively impacts patient survival. Consequently, for paramedics working in areas with low out-of-hospital cardiac arrest case volumes, ambulance services and professional bodies recognize the importance of alternative ways to maintain resuscitation skills. Simulation-based training via resuscitation manikins offers a potential solution for maintaining paramedic clinical practice skills.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The aim of the study is to examine the effectiveness of advanced technology clinical simulation manikins and accompanying simulation resources (targeted clinical scenarios and debriefing tools) in improving the demonstrable capability of paramedics to deliver high-quality patient care, as measured by external cardiac compression (ECC) performance.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A pre- and postintervention study design without a control group was used. Data were collected at the start of the manikin training forum (baseline), immediately following the training forum (time 2), and 6 to 11 months after the training forum (time 3). The study was conducted with paramedics from 95 NSW Ambulance locations (75 regional locations and 20 metropolitan locations). Eligible participants were paramedics who were employed by NSW Ambulance (N=106; 100% consent rate). As part of the intervention, paramedics attended a training session on the use of advanced technology simulation manikins. Manikins were then deployed to locations for further use. The main outcome measure was an overall compression score that was automatically recorded and calculated by the simulator manikin in 2-minute cycles. This score was derived from compressions that were fully released and with the correct hand position, adequate depth, and adequate rate.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 106 (100% consent rate) paramedics participated, primarily representing regional ambulance locations (n= 75, 78.9%). ECC compression scores were on average 95% or above at all time points, suggesting high performance. No significant differences over time (P&gt;.05) were identified for the overall ECC performance score, compressions fully released, compressions with adequate depth, or compressions with the correct hand position. However, paramedics had significantly lower odds (odds ratio 0.30, 95% CI 0.12-0.78) of achieving compressions with adequate rate at time 3 compared to time 2 (P=.01). Compressions were of a slower rate, with an average difference of 2.1 fewer compressions every minute.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Despite this difference in compression rate over time, this did not cause significant detriment to overall ECC performance. Training and deployment of simulator manikins d","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"8 ","pages":"e49895"},"PeriodicalIF":0.0,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting Key Risk Factors for Cardiovascular Disease in At-Risk Individuals: Developing a Digital, Personalized, and Real-Time Intervention to Facilitate Smoking Cessation and Physical Activity. 针对高危人群心血管疾病的关键危险因素:开发数字化、个性化和实时干预以促进戒烟和体育活动。
Q2 Medicine Pub Date : 2024-12-20 DOI: 10.2196/47730
Anke Versluis, Kristell M Penfornis, Sven A van der Burg, Bouke L Scheltinga, Milon H M van Vliet, Nele Albers, Eline Meijer

Health care is under pressure due to an aging population with an increasing prevalence of chronic diseases, including cardiovascular disease. Smoking and physical inactivity are 2 key preventable risk factors for cardiovascular disease. Yet, as with most health behaviors, they are difficult to change. In the interdisciplinary Perfect Fit project, scientists from different fields join forces to develop an evidence-based virtual coach (VC) that supports smokers in quitting smoking and increasing their physical activity. In this Viewpoint paper, intervention content, design, and implementation, as well as lessons learned, are presented to support other research groups working on similar projects. A total of 6 different approaches were used and combined to support the development of the Perfect Fit VC. The approaches used are (1) literature reviews, (2) empirical studies, (3) collaboration with end users, (4) content and technical development sprints, (5) interdisciplinary collaboration, and (6) iterative proof-of-concept implementation. The Perfect Fit intervention integrates evidence-based behavior change techniques with new techniques focused on identity change, big data science, sensor technology, and personalized real-time coaching. Intervention content of the virtual coaching matches the individual needs of the end users. Lessons learned include ways to optimally implement and tailor interactions with the VC (eg, clearly explain why the user is asked for input and tailor the timing and frequency of the intervention components). Concerning the development process, lessons learned include strategies for effective interdisciplinary collaboration and technical development (eg, finding a good balance between end users' wishes and legal possibilities). The Perfect Fit development process was collaborative, iterative, and challenging at times. Our experiences and lessons learned can inspire and benefit others. Advanced, evidence-based digital interventions, such as Perfect Fit, can contribute to a healthy society while alleviating health care burden.

由于人口老龄化,包括心血管疾病在内的慢性病发病率不断上升,医疗保健面临着巨大压力。吸烟和缺乏运动是心血管疾病的两大主要可预防风险因素。然而,与大多数健康行为一样,它们很难改变。在跨学科的 "完美健身"(Perfect Fit)项目中,来自不同领域的科学家联手开发了一种以证据为基础的虚拟教练(VC),帮助吸烟者戒烟并增加体育锻炼。在这篇 "视点 "论文中,介绍了干预的内容、设计和实施,以及吸取的经验教训,以支持其他研究小组开展类似项目。为支持 "完美契合 "自愿咨询项目的开发,共使用并结合了 6 种不同的方法。这些方法包括:(1)文献综述;(2)实证研究;(3)与最终用户合作;(4)内容和技术开发冲刺;(5)跨学科合作;(6)迭代概念验证实施。完美契合 "干预将循证行为改变技术与注重身份改变的新技术、大数据科学、传感器技术和个性化实时辅导相结合。虚拟辅导的干预内容与最终用户的个人需求相匹配。经验教训包括如何以最佳方式实施和定制与虚拟中心的互动(例如,明确解释为何要求用户提供意见,以及定制干预内容的时间和频率)。关于开发过程,经验教训包括有效的跨学科合作和技术开发战略(例如,在最终用户的愿望和法律可能性之间找到良好的平衡)。完美契合 "的开发过程是一个合作、反复和充满挑战的过程。我们的经验和教训可以启发和惠及他人。先进的、以证据为基础的数字干预措施,如 Perfect Fit,可以在减轻医疗负担的同时,为健康社会做出贡献。
{"title":"Targeting Key Risk Factors for Cardiovascular Disease in At-Risk Individuals: Developing a Digital, Personalized, and Real-Time Intervention to Facilitate Smoking Cessation and Physical Activity.","authors":"Anke Versluis, Kristell M Penfornis, Sven A van der Burg, Bouke L Scheltinga, Milon H M van Vliet, Nele Albers, Eline Meijer","doi":"10.2196/47730","DOIUrl":"10.2196/47730","url":null,"abstract":"<p><p>Health care is under pressure due to an aging population with an increasing prevalence of chronic diseases, including cardiovascular disease. Smoking and physical inactivity are 2 key preventable risk factors for cardiovascular disease. Yet, as with most health behaviors, they are difficult to change. In the interdisciplinary Perfect Fit project, scientists from different fields join forces to develop an evidence-based virtual coach (VC) that supports smokers in quitting smoking and increasing their physical activity. In this Viewpoint paper, intervention content, design, and implementation, as well as lessons learned, are presented to support other research groups working on similar projects. A total of 6 different approaches were used and combined to support the development of the Perfect Fit VC. The approaches used are (1) literature reviews, (2) empirical studies, (3) collaboration with end users, (4) content and technical development sprints, (5) interdisciplinary collaboration, and (6) iterative proof-of-concept implementation. The Perfect Fit intervention integrates evidence-based behavior change techniques with new techniques focused on identity change, big data science, sensor technology, and personalized real-time coaching. Intervention content of the virtual coaching matches the individual needs of the end users. Lessons learned include ways to optimally implement and tailor interactions with the VC (eg, clearly explain why the user is asked for input and tailor the timing and frequency of the intervention components). Concerning the development process, lessons learned include strategies for effective interdisciplinary collaboration and technical development (eg, finding a good balance between end users' wishes and legal possibilities). The Perfect Fit development process was collaborative, iterative, and challenging at times. Our experiences and lessons learned can inspire and benefit others. Advanced, evidence-based digital interventions, such as Perfect Fit, can contribute to a healthy society while alleviating health care burden.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"8 ","pages":"e47730"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11699499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142869332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metaphor Diffusion in Online Health Communities: Infodemiology Study in a Stroke Online Health Community. 隐喻在网络健康社区的扩散:中风网络健康社区的信息流行病学研究。
Q2 Medicine Pub Date : 2024-12-17 DOI: 10.2196/53696
Sara Khoshnaw, Pietro Panzarasa, Anna De Simoni

Background: Online health communities (OHCs) enable patients to create social ties with people with similar health conditions outside their existing social networks. Harnessing mechanisms of information diffusion in OHCs has attracted attention for its ability to improve illness self-management without the use of health care resources.

Objective: We aimed to analyze the novelty of a metaphor used for the first time in an OHC, assess how it can facilitate self-management of post-stroke symptoms, describe its appearance over time, and classify its diffusion mechanisms.

Methods: We conducted a passive analysis of posts written by UK stroke survivors and their family members in an online stroke community between 2004 and 2011. Posts including the term "legacy of stroke" were identified. Information diffusion was classified according to self-promotion or viral spread mechanisms and diffusion depth (the number of users the information spreads out to). Linguistic analysis was performed through the British National Corpus and the Google search engine.

Results: Post-stroke symptoms were referred to as "legacy of stroke." This metaphor was novel and appeared for the first time in the OHC in the second out of a total of 3459 threads. The metaphor was written by user A, who attributed it to a stroke consultant explaining post-stroke fatigue. This user was a "superuser" (ie, a user with high posting activity) and self-promoted the metaphor throughout the years in response to posts written by other users, in 51 separate threads. In total, 7 users subsequently used the metaphor, contributing to its viral diffusion, of which 3 were superusers themselves. Superusers achieved the higher diffusion depths (maximum of 3). Of the 7 users, 3 had been part of threads where user A mentioned the metaphor, while 2 users had been part of discussion threads in unrelated conversations. In total, 2 users had not been part of threads with any of the other users, suggesting that the metaphor was acquired through prior lurking activity.

Conclusions: Metaphors that are considered helpful by patients with stroke to come to terms with their symptoms can diffuse in OHCs through both self-promotion and social (or viral) spreading, with the main driver of diffusion being the superuser trait. Lurking activity (the most common behavior in OHCs) contributed to the diffusion of information. As an increasing number of patients with long-term conditions join OHCs to find others with similar health-related concerns, improving clinicians' and researchers' awareness of the diffusion of metaphors that facilitate self-management in health social media may be beneficial beyond the individual patient.

背景:在线健康社区(OHCs)使患者能够与现有社会网络之外具有相似健康状况的人建立社会联系。利用OHCs的信息扩散机制,在不使用卫生保健资源的情况下改善疾病自我管理的能力,引起了人们的注意。目的:我们旨在分析在OHC中首次使用的隐喻的新颖性,评估它如何促进脑卒中后症状的自我管理,描述其随时间的变化,并分类其扩散机制。方法:我们对2004年至2011年间英国中风幸存者及其家庭成员在网上中风社区所写的帖子进行了被动分析。其中包括“中风后遗症”一词。根据自我推广或病毒式传播机制和传播深度(信息传播到的用户数量)对信息传播进行分类。语言分析是通过英国国家语料库和谷歌搜索引擎进行的。结果:卒中后症状被称为“卒中后遗症”。这个比喻很新颖,在总共3459个线程中的第二个线程中首次出现在OHC中。这个比喻是用户A写的,他认为这是一位中风顾问在解释中风后的疲劳。这个用户是一个“超级用户”(即发帖活跃度很高的用户),多年来,他在51个不同的线程中回应其他用户写的帖子,自我推广了这个比喻。总共有7个用户随后使用了这个比喻,促进了它的病毒式传播,其中3个是超级用户。超级用户获得了更高的扩散深度(最多3个)。在7个用户中,有3个用户是用户A提到隐喻的线程的一部分,而2个用户是不相关对话的讨论线程的一部分。总共有2个用户没有与任何其他用户一起参与线程,这表明这个隐喻是通过先前的潜伏活动获得的。结论:被认为有助于中风患者接受其症状的隐喻可以通过自我推销和社会(或病毒)传播在ohc中传播,传播的主要驱动因素是超级用户特征。潜伏活动(OHCs中最常见的行为)有助于信息的扩散。随着越来越多患有长期疾病的患者加入健康中心,寻找其他具有类似健康相关问题的患者,提高临床医生和研究人员对促进健康社交媒体中自我管理的隐喻传播的认识,可能不仅对个体患者有益。
{"title":"Metaphor Diffusion in Online Health Communities: Infodemiology Study in a Stroke Online Health Community.","authors":"Sara Khoshnaw, Pietro Panzarasa, Anna De Simoni","doi":"10.2196/53696","DOIUrl":"10.2196/53696","url":null,"abstract":"<p><strong>Background: </strong>Online health communities (OHCs) enable patients to create social ties with people with similar health conditions outside their existing social networks. Harnessing mechanisms of information diffusion in OHCs has attracted attention for its ability to improve illness self-management without the use of health care resources.</p><p><strong>Objective: </strong>We aimed to analyze the novelty of a metaphor used for the first time in an OHC, assess how it can facilitate self-management of post-stroke symptoms, describe its appearance over time, and classify its diffusion mechanisms.</p><p><strong>Methods: </strong>We conducted a passive analysis of posts written by UK stroke survivors and their family members in an online stroke community between 2004 and 2011. Posts including the term \"legacy of stroke\" were identified. Information diffusion was classified according to self-promotion or viral spread mechanisms and diffusion depth (the number of users the information spreads out to). Linguistic analysis was performed through the British National Corpus and the Google search engine.</p><p><strong>Results: </strong>Post-stroke symptoms were referred to as \"legacy of stroke.\" This metaphor was novel and appeared for the first time in the OHC in the second out of a total of 3459 threads. The metaphor was written by user A, who attributed it to a stroke consultant explaining post-stroke fatigue. This user was a \"superuser\" (ie, a user with high posting activity) and self-promoted the metaphor throughout the years in response to posts written by other users, in 51 separate threads. In total, 7 users subsequently used the metaphor, contributing to its viral diffusion, of which 3 were superusers themselves. Superusers achieved the higher diffusion depths (maximum of 3). Of the 7 users, 3 had been part of threads where user A mentioned the metaphor, while 2 users had been part of discussion threads in unrelated conversations. In total, 2 users had not been part of threads with any of the other users, suggesting that the metaphor was acquired through prior lurking activity.</p><p><strong>Conclusions: </strong>Metaphors that are considered helpful by patients with stroke to come to terms with their symptoms can diffuse in OHCs through both self-promotion and social (or viral) spreading, with the main driver of diffusion being the superuser trait. Lurking activity (the most common behavior in OHCs) contributed to the diffusion of information. As an increasing number of patients with long-term conditions join OHCs to find others with similar health-related concerns, improving clinicians' and researchers' awareness of the diffusion of metaphors that facilitate self-management in health social media may be beneficial beyond the individual patient.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"8 ","pages":"e53696"},"PeriodicalIF":0.0,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11683652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142854329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Results of a Digital Multimodal Motivational and Educational Program as Follow-Up Care for Former Cardiac Rehabilitation Patients: Randomized Controlled Trial. 数字多模式激励和教育计划作为前心脏康复患者随访护理的结果:随机对照试验。
Q2 Medicine Pub Date : 2024-12-11 DOI: 10.2196/57960
Maxi Pia Bretschneider, Wolfgang Mayer-Berger, Jens Weine, Lena Roth, Peter E H Schwarz, Franz Petermann

Background: Digital interventions are promising additions for both usual care and rehabilitation. Evidence and studies for the latter, however, are still rare.

Objective: The aim of the study was to examine the app/web-based patient education program called "mebix" (previously called "Vision 2 - Gesundes Herz") regarding its effectiveness in relation to the parameters of disease-specific quality of life (HeartQoL), cardiovascular risk profile (Cardiovascular Risk Management [CARRISMA]), and prognostic estimation of early retirement (Screening instrument work and occupation [SIBAR]) in 190 participants from a cardiological rehabilitation clinic.

Methods: To evaluate mebix, 354 patients from the Roderbirken Clinic of the German Pension Insurance Rhineland (Germany) with a coronary heart diesase were recruited and randomized either to the intervention group (using mebix postrehabiliation for up to 12 months) or the control group (receiving standard care). The data collection took place at the end of inpatient rehabilitation (t0), as well as 6 months (t1) and 12 months (t2) after the end of rehabilitation. Analyses of variance are used to assess the overall significance of difference in outcome parameters between groups and over time.

Results: The primary endpoint of disease-related quality of life shows a significant improvement of 7.35 points over the course of the intervention that is also more pronounced in the intervention group. Similarly, the 10-year risk of cardiovascular death and myocardial infarction showed significant improvements in the cardiovascular risk profile over time and between groups, indicating better results in the intervention group (ie, a reduction of -1.59 and -5.03, respectively). Positive effects on secondary outcomes like body weight, blood pressure, and number of smokers only showed time effects, indicating no difference between the groups. In addition, the SIBAR was significantly lower/better at the end of the observation period than at the beginning of the observation for both groups.

Conclusions: Overall, the digital training program represents an effective follow-up offer after rehabilitation that could be incorporated into standard care to further improve disease-related quality of life and cardiovascular risk profiles.

背景:数字干预对于日常护理和康复都是有希望的补充。然而,后者的证据和研究仍然很少。目的:该研究的目的是检查应用程序/基于网络的患者教育项目“mebix”(以前称为“Vision 2 - Gesundes Herz”)在190名心脏病康复诊所参与者的疾病特异性生活质量(HeartQoL)、心血管风险状况(心血管风险管理[CARRISMA])和早期退休预后评估(筛查仪器工作和职业[SIBAR])参数方面的有效性。方法:为了评估mebix,从德国莱茵兰养老保险(德国)的Roderbirken诊所招募了354名冠心病患者,并随机分为干预组(使用mebix康复后长达12个月)和对照组(接受标准治疗)。数据收集在住院康复结束(t0),以及康复结束后6个月(t1)和12个月(t2)进行。方差分析用于评估组间和时间间结果参数差异的总体显著性。结果:疾病相关生活质量的主要终点在干预过程中显着提高了7.35分,在干预组中也更为明显。同样,心血管死亡和心肌梗死的10年风险随着时间的推移和组间的差异也有显著改善,表明干预组的结果更好(即分别降低-1.59和-5.03)。对体重、血压和吸烟人数等次要结果的积极影响仅表现出时间效应,表明两组之间没有差异。此外,两组患者的SIBAR在观察期结束时均明显低于或优于观察开始时。结论:总体而言,数字培训计划代表了康复后有效的随访服务,可纳入标准护理,以进一步改善疾病相关的生活质量和心血管风险概况。
{"title":"Results of a Digital Multimodal Motivational and Educational Program as Follow-Up Care for Former Cardiac Rehabilitation Patients: Randomized Controlled Trial.","authors":"Maxi Pia Bretschneider, Wolfgang Mayer-Berger, Jens Weine, Lena Roth, Peter E H Schwarz, Franz Petermann","doi":"10.2196/57960","DOIUrl":"10.2196/57960","url":null,"abstract":"<p><strong>Background: </strong>Digital interventions are promising additions for both usual care and rehabilitation. Evidence and studies for the latter, however, are still rare.</p><p><strong>Objective: </strong>The aim of the study was to examine the app/web-based patient education program called \"mebix\" (previously called \"Vision 2 - Gesundes Herz\") regarding its effectiveness in relation to the parameters of disease-specific quality of life (HeartQoL), cardiovascular risk profile (Cardiovascular Risk Management [CARRISMA]), and prognostic estimation of early retirement (Screening instrument work and occupation [SIBAR]) in 190 participants from a cardiological rehabilitation clinic.</p><p><strong>Methods: </strong>To evaluate mebix, 354 patients from the Roderbirken Clinic of the German Pension Insurance Rhineland (Germany) with a coronary heart diesase were recruited and randomized either to the intervention group (using mebix postrehabiliation for up to 12 months) or the control group (receiving standard care). The data collection took place at the end of inpatient rehabilitation (t0), as well as 6 months (t1) and 12 months (t2) after the end of rehabilitation. Analyses of variance are used to assess the overall significance of difference in outcome parameters between groups and over time.</p><p><strong>Results: </strong>The primary endpoint of disease-related quality of life shows a significant improvement of 7.35 points over the course of the intervention that is also more pronounced in the intervention group. Similarly, the 10-year risk of cardiovascular death and myocardial infarction showed significant improvements in the cardiovascular risk profile over time and between groups, indicating better results in the intervention group (ie, a reduction of -1.59 and -5.03, respectively). Positive effects on secondary outcomes like body weight, blood pressure, and number of smokers only showed time effects, indicating no difference between the groups. In addition, the SIBAR was significantly lower/better at the end of the observation period than at the beginning of the observation for both groups.</p><p><strong>Conclusions: </strong>Overall, the digital training program represents an effective follow-up offer after rehabilitation that could be incorporated into standard care to further improve disease-related quality of life and cardiovascular risk profiles.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"8 ","pages":"e57960"},"PeriodicalIF":0.0,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11653970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Inhaled Beta-2 Agonists on Heart Rate in Patients With Asthma: Sensor-Based Observational Study. 吸入β -2激动剂对哮喘患者心率的影响:基于传感器的观察性研究。
Q2 Medicine Pub Date : 2024-12-11 DOI: 10.2196/56848
Rishi Jayant Khusial, Jacob K Sont, Omar S Usmani, Matteo Bonini, Kian Fan Chung, Stephen James Fowler, Persijn J Honkoop

Background: Beta-2 agonists play an important role in the management of asthma. Inhaled long-acting beta-2 agonists (LABAs) and short-acting beta-2 agonists (SABAs) cause bronchodilation by stimulating adrenoceptors. These receptors are also present in cardiac cells and, as a side effect, could also be stimulated by inhaled beta-2 agonists.

Objective: This study aims to assess the effect of beta-2 agonists on heart rate (HR).

Methods: The data were retrieved from an observational study, the myAirCoach Quantification Campaign. Beta-2 agonist use was registered by self-reported monthly questionnaires and by smart inhalers. HR was monitored continuously with the Fitbit Charge HR tracker (Fitbit Inc). Patients (aged 18 years and older) were recruited if they had uncontrolled asthma and used inhalation medication. Our primary outcome was the difference in HR between LABA and non-LABA users. Secondary outcomes were the difference in HR on days SABAs were used compared to days SABAs were not used and an assessment of the timing of inhaler use during the day.

Results: Patients using LABA did not have a clinically relevant higher HR (average 0.8 beats per minute difference) during the day. Around the moment of SABA inhalation itself, the HR does increase steeply, and it takes 138 minutes before it returns to the normal range.

Conclusions: This study indicates that LABAs do not have a clinically relevant effect on HR. SABAs are instead associated with a short-term HR increase.

Trial registration: ClinicalTrials.gov NCT02774772; https://clinicaltrials.gov/study/NCT02774772.

背景:β -2激动剂在哮喘治疗中发挥重要作用。吸入长效β -2激动剂(LABAs)和短效β -2激动剂(SABAs)通过刺激肾上腺素受体引起支气管扩张。这些受体也存在于心脏细胞中,并且作为副作用,也可能被吸入的β -2激动剂刺激。目的:探讨β -2激动剂对心率(HR)的影响。方法:数据来自一项观察性研究,myAirCoach量化活动。β -2激动剂的使用通过每月自我报告的问卷和智能吸入器进行登记。使用Fitbit Charge HR追踪器(Fitbit Inc .)对HR进行持续监测。如果患者(18岁及以上)患有不受控制的哮喘并使用吸入药物,则招募患者。我们的主要结果是LABA和非LABA使用者之间的HR差异。次要结果是使用SABAs与不使用SABAs时HR的差异,以及白天吸入器使用时间的评估。结果:使用LABA的患者在白天没有临床相关的更高HR(平均0.8次/分钟的差异)。在吸入SABA前后,HR确实急剧增加,需要138分钟才能恢复到正常范围。结论:本研究表明LABAs对HR没有临床相关的影响。相反,SABAs与短期人力资源增加有关。试验注册:ClinicalTrials.gov NCT02774772;https://clinicaltrials.gov/study/NCT02774772。
{"title":"The Effect of Inhaled Beta-2 Agonists on Heart Rate in Patients With Asthma: Sensor-Based Observational Study.","authors":"Rishi Jayant Khusial, Jacob K Sont, Omar S Usmani, Matteo Bonini, Kian Fan Chung, Stephen James Fowler, Persijn J Honkoop","doi":"10.2196/56848","DOIUrl":"10.2196/56848","url":null,"abstract":"<p><strong>Background: </strong>Beta-2 agonists play an important role in the management of asthma. Inhaled long-acting beta-2 agonists (LABAs) and short-acting beta-2 agonists (SABAs) cause bronchodilation by stimulating adrenoceptors. These receptors are also present in cardiac cells and, as a side effect, could also be stimulated by inhaled beta-2 agonists.</p><p><strong>Objective: </strong>This study aims to assess the effect of beta-2 agonists on heart rate (HR).</p><p><strong>Methods: </strong>The data were retrieved from an observational study, the myAirCoach Quantification Campaign. Beta-2 agonist use was registered by self-reported monthly questionnaires and by smart inhalers. HR was monitored continuously with the Fitbit Charge HR tracker (Fitbit Inc). Patients (aged 18 years and older) were recruited if they had uncontrolled asthma and used inhalation medication. Our primary outcome was the difference in HR between LABA and non-LABA users. Secondary outcomes were the difference in HR on days SABAs were used compared to days SABAs were not used and an assessment of the timing of inhaler use during the day.</p><p><strong>Results: </strong>Patients using LABA did not have a clinically relevant higher HR (average 0.8 beats per minute difference) during the day. Around the moment of SABA inhalation itself, the HR does increase steeply, and it takes 138 minutes before it returns to the normal range.</p><p><strong>Conclusions: </strong>This study indicates that LABAs do not have a clinically relevant effect on HR. SABAs are instead associated with a short-term HR increase.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov NCT02774772; https://clinicaltrials.gov/study/NCT02774772.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"8 ","pages":"e56848"},"PeriodicalIF":0.0,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Cloud-Based Machine Learning Platform to Predict Clinical Outcomes at Home for Patients With Cardiovascular Conditions Discharged From Hospital: Clinical Trial. 更正:基于云的机器学习平台预测心血管疾病出院患者在家的临床结果:临床试验。
Q2 Medicine Pub Date : 2024-12-10 DOI: 10.2196/68825
Phillip C Yang, Alokkumar Jha, William Xu, Zitao Song, Patrick Jamp, Jeffrey J Teuteberg

[This corrects the article DOI: .].

[更正文章DOI: .]。
{"title":"Correction: Cloud-Based Machine Learning Platform to Predict Clinical Outcomes at Home for Patients With Cardiovascular Conditions Discharged From Hospital: Clinical Trial.","authors":"Phillip C Yang, Alokkumar Jha, William Xu, Zitao Song, Patrick Jamp, Jeffrey J Teuteberg","doi":"10.2196/68825","DOIUrl":"10.2196/68825","url":null,"abstract":"<p><p>[This corrects the article DOI: .].</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"8 ","pages":"e68825"},"PeriodicalIF":0.0,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11668986/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Video-Based Telemedicine Visits and Medication Adherence Among Patients With Heart Failure: Retrospective Cross-Sectional Study. 基于视频的远程医疗访问与心衰患者药物依从性之间的关系:回顾性横断面研究。
Q2 Medicine Pub Date : 2024-12-05 DOI: 10.2196/56763
Yaguang Zheng, Samrachana Adhikari, Xiyue Li, Yunan Zhao, Amrita Mukhopadhyay, Carine E Hamo, Tyrel Stokes, Saul Blecker
<p><strong>Background: </strong>Despite the exponential growth in telemedicine visits in clinical practice due to the COVID-19 pandemic, it remains unknown if telemedicine visits achieved similar adherence to prescribed medications as in-person office visits for patients with heart failure.</p><p><strong>Objective: </strong>Our study examined the association between telemedicine visits (vs in-person visits) and medication adherence in patients with heart failure.</p><p><strong>Methods: </strong>This was a retrospective cross-sectional study of adult patients with a diagnosis of heart failure or an ejection fraction of ≤40% using data between April 1 and October 1, 2020. This period was used because New York University approved telemedicine visits for both established and new patients by April 1, 2020. The time zero window was between April 1 and October 1, 2020, then each identified patient was monitored for up to 180 days. Medication adherence was measured by the mean proportion of days covered (PDC) within 180 days, and categorized as adherent if the PDC was ≥0.8. Patients were included in the telemedicine exposure group or in-person group if all encounters were video visits or in-person office visits, respectively. Poisson regression and logistic regression models were used for the analyses.</p><p><strong>Results: </strong>A total of 9521 individuals were included in this analysis (telemedicine visits only: n=830 in-person office visits only: n=8691). Overall, the mean age was 76.7 (SD 12.4) years. Most of the patients were White (n=6996, 73.5%), followed by Black (n=1060, 11.1%) and Asian (n=290, 3%). Over half of the patients were male (n=5383, 56.5%) and over half were married or living with partners (n=4914, 51.6%). Most patients' health insurance was covered by Medicare (n=7163, 75.2%), followed by commercial insurance (n=1687, 17.7%) and Medicaid (n=639, 6.7%). Overall, the average PDC was 0.81 (SD 0.286) and 71.3% (6793/9521) of patients had a PDC≥0.8. There was no significant difference in mean PDC between the telemedicine and in-person office groups (mean 0.794, SD 0.294 vs mean 0.812, SD 0.285) with a rate ratio of 0.99 (95% CI 0.96-1.02; P=.09). Similarly, there was no significant difference in adherence rates between the telemedicine and in-person office groups (573/830, 69% vs 6220/8691, 71.6%), with an odds ratio of 0.94 (95% CI 0.81-1.11; P=.12). The conclusion remained the same after adjusting for covariates (eg, age, sex, race, marriage, language, and insurance).</p><p><strong>Conclusions: </strong>We found similar rates of medication adherence among patients with heart failure who were being seen via telemedicine or in-person visits. Our findings are important for clinical practice because we provide real-world evidence that telemedicine can be an approach for outpatient visits for patients with heart failure. As telemedicine is more convenient and avoids transportation issues, it may be an alternative way to maintain the sam
背景:尽管由于COVID-19大流行,远程医疗就诊在临床实践中呈指数级增长,但对于心力衰竭患者,远程医疗就诊是否达到了与当面就诊相同的药物依从性,目前尚不清楚。目的:本研究探讨了心力衰竭患者远程医疗就诊(与面对面就诊)与药物依从性之间的关系。方法:这是一项回顾性横断面研究,研究对象为诊断为心力衰竭或射血分数≤40%的成年患者,数据时间为2020年4月1日至10月1日。使用这段时间是因为纽约大学批准在2020年4月1日之前对现有患者和新患者进行远程医疗访问。零时间窗口为2020年4月1日至10月1日,然后对每名确诊患者进行长达180天的监测。以180天内的平均覆盖天数比例(PDC)来衡量药物依从性,如果PDC≥0.8,则归类为坚持用药。如果所有接触都是视频访问或亲自到办公室访问,则分别将患者纳入远程医疗暴露组或面对面组。采用泊松回归和logistic回归模型进行分析。结果:共有9521人被纳入本分析(仅远程医疗就诊:n=830,仅面对面办公室就诊:n=8691)。总体而言,平均年龄为76.7岁(SD 12.4)。以白人(n=6996, 73.5%)居多,其次为黑人(n=1060, 11.1%)和亚裔(n=290, 3%)。超过一半的患者为男性(n=5383, 56.5%),超过一半的患者已婚或与伴侣同居(n=4914, 51.6%)。大多数患者的健康保险为医疗保险(n=7163, 75.2%),其次是商业保险(n=1687, 17.7%)和医疗补助(n=639, 6.7%)。总体而言,平均PDC为0.81 (SD 0.286), 71.3%(6793/9521)的患者PDC≥0.8。远程医疗组和现场办公组的平均PDC差异无统计学意义(均值0.794,SD 0.294 vs均值0.812,SD 0.285),比值为0.99 (95% CI 0.96-1.02;P = .09点)。同样,远程医疗组和现场办公室组的依从率没有显著差异(573/830,69% vs 6220/8691, 71.6%),比值比为0.94 (95% CI 0.81-1.11;P =点)。在调整协变量(如年龄、性别、种族、婚姻、语言和保险)后,结论保持不变。结论:我们发现通过远程医疗或亲自就诊的心力衰竭患者的药物依从率相似。我们的发现对临床实践很重要,因为我们提供了真实世界的证据,证明远程医疗可以成为心力衰竭患者门诊就诊的一种方法。由于远程医疗更方便,并且避免了交通问题,因此对于心力衰竭患者来说,它可能是一种替代方法,可以保持与亲自就诊相同的药物依从性。
{"title":"Association Between Video-Based Telemedicine Visits and Medication Adherence Among Patients With Heart Failure: Retrospective Cross-Sectional Study.","authors":"Yaguang Zheng, Samrachana Adhikari, Xiyue Li, Yunan Zhao, Amrita Mukhopadhyay, Carine E Hamo, Tyrel Stokes, Saul Blecker","doi":"10.2196/56763","DOIUrl":"10.2196/56763","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Despite the exponential growth in telemedicine visits in clinical practice due to the COVID-19 pandemic, it remains unknown if telemedicine visits achieved similar adherence to prescribed medications as in-person office visits for patients with heart failure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Our study examined the association between telemedicine visits (vs in-person visits) and medication adherence in patients with heart failure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This was a retrospective cross-sectional study of adult patients with a diagnosis of heart failure or an ejection fraction of ≤40% using data between April 1 and October 1, 2020. This period was used because New York University approved telemedicine visits for both established and new patients by April 1, 2020. The time zero window was between April 1 and October 1, 2020, then each identified patient was monitored for up to 180 days. Medication adherence was measured by the mean proportion of days covered (PDC) within 180 days, and categorized as adherent if the PDC was ≥0.8. Patients were included in the telemedicine exposure group or in-person group if all encounters were video visits or in-person office visits, respectively. Poisson regression and logistic regression models were used for the analyses.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 9521 individuals were included in this analysis (telemedicine visits only: n=830 in-person office visits only: n=8691). Overall, the mean age was 76.7 (SD 12.4) years. Most of the patients were White (n=6996, 73.5%), followed by Black (n=1060, 11.1%) and Asian (n=290, 3%). Over half of the patients were male (n=5383, 56.5%) and over half were married or living with partners (n=4914, 51.6%). Most patients' health insurance was covered by Medicare (n=7163, 75.2%), followed by commercial insurance (n=1687, 17.7%) and Medicaid (n=639, 6.7%). Overall, the average PDC was 0.81 (SD 0.286) and 71.3% (6793/9521) of patients had a PDC≥0.8. There was no significant difference in mean PDC between the telemedicine and in-person office groups (mean 0.794, SD 0.294 vs mean 0.812, SD 0.285) with a rate ratio of 0.99 (95% CI 0.96-1.02; P=.09). Similarly, there was no significant difference in adherence rates between the telemedicine and in-person office groups (573/830, 69% vs 6220/8691, 71.6%), with an odds ratio of 0.94 (95% CI 0.81-1.11; P=.12). The conclusion remained the same after adjusting for covariates (eg, age, sex, race, marriage, language, and insurance).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;We found similar rates of medication adherence among patients with heart failure who were being seen via telemedicine or in-person visits. Our findings are important for clinical practice because we provide real-world evidence that telemedicine can be an approach for outpatient visits for patients with heart failure. As telemedicine is more convenient and avoids transportation issues, it may be an alternative way to maintain the sam","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"8 ","pages":"e56763"},"PeriodicalIF":0.0,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11637490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142785841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of an mHealth App (Kencom) on Patients With Untreated Hypertension Initiating Antihypertensive Medications: Real-World Cohort Study. 移动健康应用程序(Kencom)对未经治疗的高血压患者开始抗高血压药物的影响:真实世界队列研究
Q2 Medicine Pub Date : 2024-11-26 DOI: 10.2196/52266
Koichiro Matsumura, Atsushi Nakagomi, Eijiro Yagi, Nobuhiro Yamada, Yohei Funauchi, Kazuyoshi Kakehi, Ayano Yoshida, Takayuki Kawamura, Masafumi Ueno, Gaku Nakazawa, Takahiro Tabuchi

Background: To prevent the further development of cardiovascular diseases, it is a growing global priority to detect untreated hypertension in patients and ensure adequate blood pressure control via drug therapy. However, few effective tools that facilitate the initiation of antihypertensive medications among such patients have been identified.

Objective: We aimed to determine whether a mobile health (mHealth) app facilitates the initiation of antihypertensive medications among patients with untreated hypertension.

Methods: We analyzed a large longitudinal integrated database mainly comprised of data from middle-aged, employed people and their families. The database contained data from health checkups, health insurance claims, and the mHealth app kencom. kencom is used to manage daily life logs (eg, weight, number of steps) and to provide health information tailored to customers. Patients with untreated hypertension were identified using the baseline health checkup data, and follow-up health checkups were conducted to identify the rate of initiation of antihypertensive medications between mHealth app users and nonusers. Antihypertensive medication status was confirmed via a questionnaire administered during the medical checkup as well as a review of the health insurance claims database. We conducted a modified Poisson regression analysis, weighted by inverse probability of treatment weighting, to examine the effect of mHealth app usage on the initiation of antihypertensive medications. Additionally, data from four lifestyle questionnaires from the baseline and follow-up health checkups were collected to evaluate lifestyle modifications that could be attributed to the mHealth app.

Results: Data were collected from 50,803 eligible patients (mean age 49, SD 9 years; men n=39,412, 77.6%; women n=11,391, 22.4%) with a median follow-up period of 3.0 (IQR 2.3-3.1) years. The rate of initiation of antihypertensive medications was significantly higher in the mHealth app user group than in the nonuser group: 23.4% (3482/14,879) versus 18.5% (6646/35,924; P<.001), respectively. The risk ratio of mHealth app usage for initiated antihypertensive medications was 1.28 (95% CI 1.23-1.33). Among those who did not intend to improve their lifestyle habits such as exercise and diet at baseline, the rate of lifestyle improvement at follow-up was compared between mHealth app users and nonusers, using data from the questionnaires; mHealth app users demonstrated a significantly higher rate of lifestyle changes than nonusers.

Conclusions: For patients with untreated hypertension, the use of the mHealth app kencom, which was not dedicated to hypertension treatment, was associated with a higher initiation of antihypertensive medications.

背景:为了预防心血管疾病的进一步发展,发现未经治疗的高血压患者并通过药物治疗确保适当的血压控制已成为全球日益重视的问题。然而,在这些患者中,很少有有效的工具可以促进抗高血压药物的开始。目的:我们旨在确定移动健康(mHealth)应用程序是否有助于未经治疗的高血压患者开始服用降压药物。方法:对以中年就业者及其家庭数据为主的大型纵向综合数据库进行分析。该数据库包含来自健康检查、健康保险索赔和移动健康应用程序kencom的数据。Kencom用于管理日常生活日志(例如,体重,步数)并为客户提供量身定制的健康信息。使用基线健康检查数据确定未经治疗的高血压患者,并进行后续健康检查,以确定移动健康应用程序用户和非用户之间抗高血压药物的起始率。通过体检期间的问卷调查以及对健康保险索赔数据库的审查,确认了抗高血压药物治疗状况。我们进行了修正泊松回归分析,通过治疗权重的逆概率加权,来检验移动健康应用程序使用对抗高血压药物起始的影响。此外,收集了来自基线和随访健康检查的四份生活方式问卷的数据,以评估可能归因于移动健康应用程序的生活方式改变。结果:收集了来自50,803名符合条件的患者的数据(平均年龄49岁,SD 9岁;男性n= 39412, 77.6%;女性n=11,391(22.4%),中位随访期为3.0年(IQR为2.3-3.1)。mHealth应用程序用户组的抗高血压药物启动率显著高于非用户组:23.4%(3482/ 14879)对18.5% (6646/35,924);结论:对于未经治疗的高血压患者,使用非专用于高血压治疗的移动健康应用程序kencom与更高的抗高血压药物起始率相关。
{"title":"Impact of an mHealth App (Kencom) on Patients With Untreated Hypertension Initiating Antihypertensive Medications: Real-World Cohort Study.","authors":"Koichiro Matsumura, Atsushi Nakagomi, Eijiro Yagi, Nobuhiro Yamada, Yohei Funauchi, Kazuyoshi Kakehi, Ayano Yoshida, Takayuki Kawamura, Masafumi Ueno, Gaku Nakazawa, Takahiro Tabuchi","doi":"10.2196/52266","DOIUrl":"10.2196/52266","url":null,"abstract":"<p><strong>Background: </strong>To prevent the further development of cardiovascular diseases, it is a growing global priority to detect untreated hypertension in patients and ensure adequate blood pressure control via drug therapy. However, few effective tools that facilitate the initiation of antihypertensive medications among such patients have been identified.</p><p><strong>Objective: </strong>We aimed to determine whether a mobile health (mHealth) app facilitates the initiation of antihypertensive medications among patients with untreated hypertension.</p><p><strong>Methods: </strong>We analyzed a large longitudinal integrated database mainly comprised of data from middle-aged, employed people and their families. The database contained data from health checkups, health insurance claims, and the mHealth app kencom. kencom is used to manage daily life logs (eg, weight, number of steps) and to provide health information tailored to customers. Patients with untreated hypertension were identified using the baseline health checkup data, and follow-up health checkups were conducted to identify the rate of initiation of antihypertensive medications between mHealth app users and nonusers. Antihypertensive medication status was confirmed via a questionnaire administered during the medical checkup as well as a review of the health insurance claims database. We conducted a modified Poisson regression analysis, weighted by inverse probability of treatment weighting, to examine the effect of mHealth app usage on the initiation of antihypertensive medications. Additionally, data from four lifestyle questionnaires from the baseline and follow-up health checkups were collected to evaluate lifestyle modifications that could be attributed to the mHealth app.</p><p><strong>Results: </strong>Data were collected from 50,803 eligible patients (mean age 49, SD 9 years; men n=39,412, 77.6%; women n=11,391, 22.4%) with a median follow-up period of 3.0 (IQR 2.3-3.1) years. The rate of initiation of antihypertensive medications was significantly higher in the mHealth app user group than in the nonuser group: 23.4% (3482/14,879) versus 18.5% (6646/35,924; P<.001), respectively. The risk ratio of mHealth app usage for initiated antihypertensive medications was 1.28 (95% CI 1.23-1.33). Among those who did not intend to improve their lifestyle habits such as exercise and diet at baseline, the rate of lifestyle improvement at follow-up was compared between mHealth app users and nonusers, using data from the questionnaires; mHealth app users demonstrated a significantly higher rate of lifestyle changes than nonusers.</p><p><strong>Conclusions: </strong>For patients with untreated hypertension, the use of the mHealth app kencom, which was not dedicated to hypertension treatment, was associated with a higher initiation of antihypertensive medications.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"8 ","pages":"e52266"},"PeriodicalIF":0.0,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11612529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142768965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Auscultation Quality Using Contemporary Digital Stethoscopes. 使用当代数字听诊器的听诊质量比较
Q2 Medicine Pub Date : 2024-11-08 DOI: 10.2196/54746
Norah Saraya, Jonathon McBride, Karandeep Singh, Omar Sohail, Porag Jeet Das
{"title":"Comparison of Auscultation Quality Using Contemporary Digital Stethoscopes.","authors":"Norah Saraya, Jonathon McBride, Karandeep Singh, Omar Sohail, Porag Jeet Das","doi":"10.2196/54746","DOIUrl":"10.2196/54746","url":null,"abstract":"","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"8 ","pages":"e54746"},"PeriodicalIF":0.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11584529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Development of Heart Failure Electronic-Message Driven Tips to Support Self-Management: Co-Design Case Study. 开发支持自我管理的心力衰竭电子信息驱动提示:共同设计案例研究。
Q2 Medicine Pub Date : 2024-11-07 DOI: 10.2196/57328
Caleb Ferguson, Scott William, Sabine M Allida, Jordan Fulcher, Alicia J Jenkins, Jo-Dee Lattimore, L-J Loch, Anthony Keech

Background: Heart failure (HF) is a complex syndrome associated with high morbidity and mortality and increased health care use. Patient education is key to improving health outcomes, achieved by promoting self-management to optimize medical management. Newer digital tools like SMS text messaging and smartphone apps provide novel patient education approaches.

Objective: This study aimed to partner with clinicians and people with lived experience of HF to identify the priority educational topic areas to inform the development and delivery of a bank of electronic-message driven tips (e-TIPS) to support HF self-management.

Methods: We conducted 3 focus groups with cardiovascular clinicians, people with lived experience of HF, and their caregivers, which consisted of 2 stages: stage 1 (an exploratory qualitative study to identify the unmet educational needs of people living with HF; previously reported) and stage 2 (a co-design feedback session to identify educational topic areas and inform the delivery of e-TIPS). This paper reports the findings of the co-design feedback session.

Results: We identified 5 key considerations in delivering e-TIPS and 5 relevant HF educational topics for their content. Key considerations in e-TIP delivery included (1) timing of the e-TIPS; (2) clear and concise e-TIPS; (3) embedding a feedback mechanism; (4) distinguishing actionable and nonactionable e-TIPS; and (5) frequency of e-TIP delivery. Relevant educational topic areas included the following: (1) cardiovascular risk reduction, (2) self-management, (3) food and nutrition, (4) sleep hygiene, and (5) mental health.

Conclusions: The findings from this co-design case study have provided a foundation for developing a bank of e-TIPS. These will now be evaluated for usability in the BANDAIDS e-TIPS, a single-group, quasi-experimental study of a 24-week e-TIP program (personalized educational messages) delivered via SMS text messaging (ACTRN12623000644662).

背景:心力衰竭(HF)是一种复杂的综合征,具有发病率高、死亡率高、医疗费用高的特点。患者教育是改善健康状况的关键,通过促进自我管理来优化医疗管理。短信和智能手机应用程序等新型数字工具提供了新颖的患者教育方法:本研究旨在与临床医生和有高血压生活经验的人合作,确定优先教育主题领域,为开发和提供电子信息驱动的提示库(e-TIPS)提供信息,以支持高血压自我管理:我们与心血管临床医生、高血压患者及其护理人员开展了 3 次焦点小组讨论,讨论分为两个阶段:第一阶段(探索性定性研究,以确定高血压患者尚未满足的教育需求;此前已有报道)和第二阶段(共同设计反馈会议,以确定教育主题领域并为电子提示信息的提供提供依据)。本文报告了共同设计反馈会议的结果:结果:我们确定了实施 e-TIPS 的 5 个主要考虑因素和 5 个相关的高频教育主题。提供 e-TIPS 的主要考虑因素包括:(1)e-TIPS 的时间安排;(2)清晰简洁的 e-TIPS;(3)嵌入反馈机制;(4)区分可采取行动和不可采取行动的 e-TIPS;以及(5)提供 e-TIPS 的频率。相关的教育主题领域包括(1) 降低心血管风险;(2) 自我管理;(3) 食物与营养;(4) 睡眠卫生;(5) 心理健康:这项共同设计案例研究的结果为开发电子 TIPS 库奠定了基础。现在将在 BANDAIDS e-TIPS 项目中对其可用性进行评估,该项目是一项单组准实验研究,研究内容是通过 SMS 短信(ACTRN12623000644662)发送为期 24 周的 e-TIP 计划(个性化教育信息)。
{"title":"The Development of Heart Failure Electronic-Message Driven Tips to Support Self-Management: Co-Design Case Study.","authors":"Caleb Ferguson, Scott William, Sabine M Allida, Jordan Fulcher, Alicia J Jenkins, Jo-Dee Lattimore, L-J Loch, Anthony Keech","doi":"10.2196/57328","DOIUrl":"10.2196/57328","url":null,"abstract":"<p><strong>Background: </strong>Heart failure (HF) is a complex syndrome associated with high morbidity and mortality and increased health care use. Patient education is key to improving health outcomes, achieved by promoting self-management to optimize medical management. Newer digital tools like SMS text messaging and smartphone apps provide novel patient education approaches.</p><p><strong>Objective: </strong>This study aimed to partner with clinicians and people with lived experience of HF to identify the priority educational topic areas to inform the development and delivery of a bank of electronic-message driven tips (e-TIPS) to support HF self-management.</p><p><strong>Methods: </strong>We conducted 3 focus groups with cardiovascular clinicians, people with lived experience of HF, and their caregivers, which consisted of 2 stages: stage 1 (an exploratory qualitative study to identify the unmet educational needs of people living with HF; previously reported) and stage 2 (a co-design feedback session to identify educational topic areas and inform the delivery of e-TIPS). This paper reports the findings of the co-design feedback session.</p><p><strong>Results: </strong>We identified 5 key considerations in delivering e-TIPS and 5 relevant HF educational topics for their content. Key considerations in e-TIP delivery included (1) timing of the e-TIPS; (2) clear and concise e-TIPS; (3) embedding a feedback mechanism; (4) distinguishing actionable and nonactionable e-TIPS; and (5) frequency of e-TIP delivery. Relevant educational topic areas included the following: (1) cardiovascular risk reduction, (2) self-management, (3) food and nutrition, (4) sleep hygiene, and (5) mental health.</p><p><strong>Conclusions: </strong>The findings from this co-design case study have provided a foundation for developing a bank of e-TIPS. These will now be evaluated for usability in the BANDAIDS e-TIPS, a single-group, quasi-experimental study of a 24-week e-TIP program (personalized educational messages) delivered via SMS text messaging (ACTRN12623000644662).</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"8 ","pages":"e57328"},"PeriodicalIF":0.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11563649/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JMIR Cardio
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1